Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care

C Feudtner1, R M Hays, G Haynes

  • 1Child Health Institute, University of Washington, USA. feudtner@u.washington.edu

Pediatrics
|June 5, 2001
PubMed

Insights

Pediatric deaths from complex chronic conditions (CCCs) have declined, but supportive care services are still needed for infants, children, and young adults with ongoing or end-of-life needs.

Area of Science:

  • Pediatric Medicine
  • Public Health
  • Epidemiology

Background:

  • Children with complex chronic conditions (CCCs) may require pediatric supportive care services.
  • The extent and trends of this population are not well understood.

Purpose of the Study:

  • To analyze trends in deaths attributed to pediatric CCCs over two decades (1979-1997).
  • To examine death counts and rates by cause and age group.
  • To determine the number of children living within six months of death from CCCs.

Main Methods:

  • Retrospective cohort study using national death certificate and census data (1979-1997).
  • Included individuals aged 0-24 years in the United States.
  • CCCs defined by ICD-9 codes across various conditions.

Main Results:

  • In 1979-1997, 5% of deaths in 0-24 year olds were from cancer CCCs, 16% from noncancer CCCs.
  • Overall CCC-attributed death counts and rates trended downward.
  • Significant declines were observed for noncancer CCCs in infants/children and cancer CCCs in older children/young adults.

Conclusions:

  • Population-based planning for pediatric supportive care should consider both time-limited (bereavement) and ongoing (hospice) needs.
  • Services must cater to a wide range of CCCs from infancy through adulthood.
Abstract

Related Concept Videos

Current Trends in Nursing I01:28

Current Trends in Nursing I

Current trends in nursing include:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...